By-health Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
April 28, 2022 at 05:54 am EDT
Share
By-health Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 2,280.27 million compared to CNY 2,222.5 million a year ago. Revenue was CNY 2,280.27 million compared to CNY 2,222.5 million a year ago. Net income was CNY 663.01 million compared to CNY 816.3 million a year ago. Basic earnings per share from continuing operations was CNY 0.39 compared to CNY 0.52 a year ago. Diluted earnings per share from continuing operations was CNY 0.39 compared to CNY 0.51 a year ago.
Byhealth Co Ltd is a China-based company mainly engaged in the research, development, production and sales of dietary nutritional supplements. The Company's main products include glucosamine chondroitin vitamin D calcium tablets, natto red yeast and ginkgo leaf capsules, pueraria curcuma collagen tablets, donkey-hide gelatin angelica astragalus tablets, fish oil soft capsules, glucosamine chondroitin sulfate collagen peptide tablets and glucosamine chondroitin sulfate calcium tablets. The Company's main product categories include immune-boosting products, women's health products, bone health products and vitamins. The Company's products are mainly sold online and offline through brands such as By-Health, Jianliduo and Lifespace. The Company mainly conducts its businesses in domestic and overseas markets.